Cell culture protein surface coating is performed to help cell growth during in vitro isolation and cultivation. The inner surface of the Petri dish is coated with extracellular matrix components or proteins such as fibronectin, laminin, collagen, vitronectin, and osteopontin, which can be derived from humans, animal, and plants, or even synthetically made.
The Global Cell Culture Protein Surface Coating Market is expected to post a CAGR of 12.91 percent from 2014-2019, thanks to the wide range of applications for protein surface coatings:
TechNavio has pinpointed the top five market growth drivers in the Global Cell Culture Protein Surface Coating Market:
Growing Focus on Stem Cell Research
The high potential of stem cells in the treatment of severe diseases, including neurodegenerative diseases, cardiac diseases, and even diabetes, has resulted in demand for advanced cell culture products for stem cell production and study. Cell culture protein surface coating products help researchers improve the adhesion, proliferation, and growth of cultured cells.
Increased Demand for Biopharmaceuticals
Biopharmaceuticals are protein-based products such as vaccines, somatic cells, allergenics, and recombinant therapeutic proteins that are derived through cell culture. There has been increased demand for biopharmaceuticals, since they can be used to treat diseases and injuries more effectively than conventional drugs.
Several big biopharmaceutical companies such as Roche, Novo Nordisk, and EMD Millipore are involved in biopharmaceutical production, and they require high accuracy and efficiency in their cell culture applications. Since cell culture protein surface coating has been shown to facilitate cell adhesion, and delivers high productivity in cell culture activities, these products are now in high demand in the biopharmaceuticals sector.
Demand for Tissue and Organ Transplants
Stem cells can be used to regenerate a particular type of tissue or organ, and researchers have increased their efforts to produce in vitro tissues and organs for transplant procedures. For example, artificial skin is being produced using tissue cultures and can be used for to treat burn victims.
High Investment in R&D
The presence of developed healthcare infrastructure and government funding for companies is encouraging extensive R&D in the Global Cell Culture Surface Coating Market. Big pharmaceutical and biotechnology companies are investing extensively in R&D to develop innovative products to meet customer demand. High-end cell culture protein surface coating products can be used in many applications such as drug development, cell biology, tissue engineering, and biopharmaceutical production to increase efficiency and productivity.
Demand for Animal-Free Synthetic Protein Surface Coating
In 2014, animal derived proteins (aka proteins derived from animal blood) accounted for 37.83 percent of the overall market, with human-derived proteins accounting for 29.99 percent of the market.
But demand for animal-free synthetic protein surface coatings is increasing, as these proteins have a broad range of applications in several areas including biopharmaceutical production and other research. There is massive demand from both the biotechnology and pharmaceutical sectors, since animal-free synthetic protein surface coating can significantly reduce the risk of contamination.
Vendors in the market are now turning their focus to the development of animal-free synthetic protein surface coating products to meet increased demand from the industry. For instance, BD offers PureCoat ECM Mimetic Cultureware, which is coated with synthetic animal-free peptides that provide optimal cell binding and signaling in a wide range of xeno-free, serum-free, and animal-free media formulations.
